Prior to the advent of targeted therapies, there were few options other than chemotherapy for the treatment of patients with indolent B-cell lymphomas or chronic lymphocytic leukemia.
Thomas J. Kipps, MD
Advertisement
Articles by Thomas J. Kipps, MD
Advertisement
Latest Updated Articles
- How Do Targeted Therapies Change the Management of Indolent Lymphomas?
Published: September 15th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
KRd Appears to Exhibit Greater Outcomes in Standard-Risk Multiple Myeloma
2
ADCE-D01 Earns FDA Fast Track Designation in Soft Tissue Sarcoma
3
Serplulimab Plus Chemo Meets EFS End Point in Early-Stage Gastric Cancer
4
212Pb-Dotamtate Prolongs Responses in Advanced GEP-NETs
5
